Setting the Standard Since 1971
Cart 0

Injectable Drug Compatibility News

New IV Drug Compatibility & Stability Summer 2022

In this update we added a new monograph for FOSDENOPTERIN HYDROBROMIDE. We also added new stability information to the monographs for DOBUTAMINE HYDROCHLORIDE, IRON DEXTRAN, and ZICONOTIDE. New compatibility information was added to the existing drug monograph for CEFIDEROCOL SULFATE TOSYLATE with 91 different parenteral drugs.

Read more →


New IV Compatibility & Stability Spring 2022

In this update we added a new monograph for CASIMERSEN. We also added new stability information for for AMPICILLIN SODIUM and INSULIN, REGULAR. New compatibility information was added to these existing drug monographs: MEROPENEM with 101 other drugs, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VORICONAZOLE.

Read more →


New IV Drug Compatibility & Stability - Winter 2021

In this update we added new monographs for ATEZOLIZUMAB and TRILACICLIB. We also added new stability information to COVID-19 VACCINE, mRNA, and to 48 other existing drug monographs. New compatibility information was added to these existing drug monographs: CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, FOSPHENYTOIN, LEVETIRACETAM, NALOXONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, PROPOFOL, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN. View Past Updates... Available for pre-order2022 Y-Site Compatibility Wall Charts This 27" x 27" poster is laminated and includes compatibility of 122 drugs and 4 infusion fluids updated with new data that has appeared in the complete King® Guide to...

Read more →


New IV Drug Compatibility & Stability - Fall 2021

5 New drugs
New compatibility for 38 drugs
New stability for 4 drugs

Read more →


New IV Drug Compatibility & Stability - Summer 2021

In this update we added new monographs for for COVID-19 VACCINE (JANSSEN), TAFASITAMAB-CXIX, and VILTOLARSEN. We also added new stability information to these existing drug monographs:  AMIODARONE HYDROCHLORIDE, AZTREONAM, CEFEPIME HYDROCHLORIDE, CEFTAZIDIME, COVID-19 VACCINE (PFIZER-BIONTECH), IMIPENEM-CILASTATIN, ISOSORBIDE DINITRATE, KETAMINE HYDROCHLORIDE, LORAZEPAM, MEROPENEM, PIPERACILLIN AND TAZOBACTAM, and VALPROATE SODIUM. New compatibility information was added to these existing drug monographs: ALPROSTADIL, CALCIUM GLUCONATE, CEFAZOLIN SODIUM, CEFTAZIDIME, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FUROSEMIDE, GENTAMICIN SULFATE, INSULIN, REGULAR, TRAMADOL HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MILRINONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, ONDANSETRON HYDROCHLORIDE, PERITONEAL DIALYSIS SOLUTIONS, and VANCOMYCIN HYDROCHLORIDE.

Read more →